when it's okay to combine renin-angiotensin system blockers...ACEIs, ARBs, or aliskiren (Tekturna, etc)

See the FDA's April 2012 safety notice concerning the use of Aliskiren (Tekturna) with ACEIs or ARBs

You'll hear debate about when it's okay to combine renin-angiotensin system blockers...ACEIs, ARBs, or aliskiren (Tekturna, etc).

Some experts hoped that combining these would improve outcomes.

But there's growing evidence that these combos usually don't provide any additional benefit...and are sometimes harmful.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote